Unknown

Dataset Information

0

Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.


ABSTRACT: Structure-based design, synthesis, and biological evaluation of a series of novel HIV-1 protease inhibitors are described. In an effort to enhance interactions with protease backbone atoms, we have incorporated stereochemically defined methyl-2-pyrrolidinone and methyl oxazolidinone as the P1'-ligands. These ligands are designed to interact with Gly-27' carbonyl and Arg-8 side chain in the S1'-subsite of the HIV protease. We have investigated the potential of these ligands in combination with our previously developed bis-tetrahydrofuran (bis-THF) and cyclopentanyltetrahydrofuran (Cp-THF) as the P2-ligands. Inhibitor 19b with a (R)-aminomethyl-2-pyrrolidinone and a Cp-THF was shown to be the most potent compound. This inhibitor maintained near full potency against multi-PI-resistant clinical HIV-1 variants. A high resolution protein-ligand X-ray crystal structure of 19b-bound HIV-1 protease revealed that the P1'-pyrrolidinone heterocycle and the P2-Cp-ligand are involved in several critical interactions with the backbone atoms in the S1' and S2 subsites of HIV-1 protease.

SUBMITTER: Ghosh AK 

PROVIDER: S-EPMC2745609 | biostudies-literature | 2009 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.

Ghosh Arun K AK   Leshchenko-Yashchuk Sofiya S   Anderson David D DD   Baldridge Abigail A   Noetzel Marcus M   Miller Heather B HB   Tie Yunfeng Y   Wang Yuan-Fang YF   Koh Yasuhiro Y   Weber Irene T IT   Mitsuya Hiroaki H  

Journal of medicinal chemistry 20090701 13


Structure-based design, synthesis, and biological evaluation of a series of novel HIV-1 protease inhibitors are described. In an effort to enhance interactions with protease backbone atoms, we have incorporated stereochemically defined methyl-2-pyrrolidinone and methyl oxazolidinone as the P1'-ligands. These ligands are designed to interact with Gly-27' carbonyl and Arg-8 side chain in the S1'-subsite of the HIV protease. We have investigated the potential of these ligands in combination with ou  ...[more]

Similar Datasets

| S-EPMC4765732 | biostudies-literature
| S-EPMC5647257 | biostudies-literature
| S-EPMC4765733 | biostudies-literature
| S-EPMC5360270 | biostudies-literature
| S-EPMC2812926 | biostudies-literature
| S-EPMC3164320 | biostudies-literature
| S-EPMC2797486 | biostudies-literature
| S-EPMC4133278 | biostudies-literature
| S-EPMC3800042 | biostudies-literature
| S-EPMC3862176 | biostudies-literature